HOLX - Hologic - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

HOLX is currently covered by 13 analysts with an average price target of $77.64. This is a potential upside of $9.73 (14.33%) from yesterday's end of day stock price of $67.91.

Hologic's activity chart (see below) currently has 336 price targets and 283 ratings on display. The stock rating distribution of HOLX is 48.08% BUY and 51.92% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.83% with an average time for these price targets to be met of 212 days.

Highest price target for HOLX is $94, Lowest price target is $68, average price target is $77.44.

Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 31-Jul-2025. First documented stock forecast 24-Sep-2013.

Best performing analysts who are covering HOLX - Hologic:

Andrew Cooper Dan Leonard Tejas Savant Jayson Bedford Ryan Zimmerman Puneet Souda Mike Matson William Quirk Isaac Ro Richard Newitter

Currently out of the existing stock ratings of HOLX, 25 are a BUY (48.08%), 27 are a HOLD (51.92%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Tejas Savant (MORGAN STANLEY)

Hold

$69

$2.18 (3.26%)

$65

4 days ago
(31-Jul-2025)

6/11 (54.55%)

$2.18 (3.26%)

Please subscribe to see the analyst performance score

Anthony Petrone (MIZUHO)

Buy

$70

$3.18 (4.76%)

$87

19 days ago
(16-Jul-2025)

1/9 (11.11%)

$6.14 (9.61%)

Please subscribe to see the analyst performance score

Vijay Kumar (EVERCORE)

Hold

$68

$1.18 (1.77%)

$62

27 days ago
(08-Jul-2025)

19/22 (86.36%)

$3.1 (4.78%)

179

Please subscribe to see the analyst performance score

Mike Matson (NEEDHAM)

Hold

2 months 7 days ago
(28-May-2025)

14/25 (56%)

$18.28 (25.49%)

168

Please subscribe to see the analyst performance score

Mason Carrico (STEPHENS)

Buy

$70

$3.18 (4.76%)

$84

2 months 22 days ago
(13-May-2025)

0/4 (0%)

$12.88 (22.55%)

Please subscribe to see the analyst performance score

Show more analysts

Load Price Targets and Ratings Chart

To gain access for the analyst/ stock price target chart please use a computer

What is HOLX (Hologic) average time for price targets to be met?

On average it took 212 days on average for the stock forecasts to be realized with a an average price target met ratio 66.83

Which analyst has the current highest performing score on HOLX (Hologic) with a proven track record?

ANDREW COOPER

Which analyst has the most public recommendations on HOLX (Hologic)?

Andrew Cooper works at RAYMOND JAMES and has 13 price targets and 9 ratings on HOLX

Which analyst is the currently most bullish on HOLX (Hologic)?

Max Masucci with highest potential upside - $31.76

Which analyst is the currently most reserved on HOLX (Hologic)?

Jack Meehan with lowest potential downside - -$19.82

Hologic in the News

Hologic (HOLX) Q3 Revenue Beats 1%

Key Points GAAP revenue of $1.02 billion for Q3 FY2025 exceeded expectations and guidance, driven by higher Diagnostics and Surgical sales. Non-GAAP earnings per share reached $1.08, beating analyst estimates for non-GAAP EPS and GAAP revenue and prior-year performance. Organic Breast Health revenue declined 10.1%, while tariff headwinds and margin pressure emerged as concerns.These 10...

Hologic Inc (HOLX) Q3 2025 Earnings Call Highlights: Surpassing Expectations Amidst Challenges

Total Revenue: $1.024 billion, a slight growth of 0.4%, exceeding guidance by $14 million. Non-GAAP Earnings Per Share (EPS): $1.08, a 1.9% increase year-over-year, exceeding guidance by a penny. Non-GAAP Operating Margin: Just above 30%. Diagnostics Revenue: $448.9 million, 0.9% growth, 2.9% organically excluding COVID-related sales. Breast Health Revenue: $365.2 million, declined 5.8%, 10.8% organically...